Bristol-Myers to Take a $3B Tax Hit in Q4 2017 Post author:Sam Post published:January 7, 2018 Post category:BioPharma The expense is primarily related to taxes on unremitted offshore earnings, the company said. Source: BioSpace You Might Also Like 4 Critical Takeaways From 3D Systems??? Q4 Earnings Call March 6, 2017 XW Laboratories Inc. Secures Over $17M Series B Financing Led By And September 19, 2017 Thermo Fisher Scientific Declares Quarterly Dividend February 28, 2017